
Apex Biotechnologies Private Limited
Provides engineering and technology solutions for living organisms through research and consultations.
Provides engineering and technology solutions for living organisms through research and consultations.
Apex Biotechnologies Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 September 2004 and has a history of 20 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gurupreet Sangla, Harvinder Singh, Ashok Wadia, and One other member serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U01409DL2004PTC129583
129583
Private Limited Indian Non-Government Company
30 Sep 2004
20 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gurupreet Sangla ![]() | Director | 28-Jan-2022 | Current |
Harvinder Singh ![]() | Director | 30-Sep-2004 | Current |
Ashok Wadia ![]() | Director | 28-Jan-2022 | Current |
Ishita Wadia ![]() | Director | 11-Feb-2023 | Current |
Apex Biotechnologies Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.27%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth |
| ||||||
EBITDA |
|
In 2018, Apex Biotechnologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Gurupreet Sangla, Harvinder Singh and 1 more are mutual person
Harvinder Singh is a mutual person
Gurupreet Sangla and Harvinder Singh are mutual person
Ishita Wadia is a mutual person
Ashok Wadia and Ishita Wadia are mutual person
Gurupreet Sangla and Harvinder Singh are mutual person
₹0
₹30.00 M
Date | Lender | Amount | Status |
---|---|---|---|
27 Dec 2008 | Syndicate Bank | ₹3.00 Cr | Satisfied |
Unlock and access historical data on people associated with Apex Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Apex Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Biotechnologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Apex Biotechnologies Private Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records.
Apex Biotechnologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ishita Wadia was appointed as a Director was appointed as a Director on 11 Feb 2023 & has been associated with this company since 2 years 26 days .
Gurupreet Sangla was appointed as a Director was appointed as a Director on 28 Jan 2022 & has been associated with this company since 3 years 1 month .
Ashok Wadia was appointed as a Director was appointed as a Director on 28 Jan 2022 & has been associated with this company since 3 years 1 month .
A charge registered on 27 Dec 2008 via Charge ID 10138854 with Syndicate Bank was fully satisfied on 26 May 2011.
Apex Biotechnologies Private Limited was incorporated on 30 Sep 2004.
The authorized share capital of Apex Biotechnologies Private Limited is ₹ 0.20 M and paid-up capital is ₹ 0.10 M.
Currently 4 directors are associated with Apex Biotechnologies Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Apex Biotechnologies Private Limited is 111, Okhla Industrial Estate Phase-Iii India, New Delhi, 110020.
The corporate identification number (CIN) of Apex Biotechnologies Private Limited is U01409DL2004PTC129583 and the company number is 129583 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2021 indicates that The net worth of Apex Biotechnologies Private Limited has experienced an downturn of -1.27%.
The most recent Balance Sheet for Apex Biotechnologies Private Limited was filed with the ROC on 31 Mar 2024.
PW